Welcome to LookChem.com Sign In|Join Free
  • or
3-CHLOROMETHYL-4-HYDROXY-5-METHOXYBENZALDEHYDE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

28276-04-2

Post Buying Request

28276-04-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

28276-04-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 28276-04-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,2,7 and 6 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 28276-04:
(7*2)+(6*8)+(5*2)+(4*7)+(3*6)+(2*0)+(1*4)=122
122 % 10 = 2
So 28276-04-2 is a valid CAS Registry Number.

28276-04-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(chloromethyl)-4-hydroxy-5-methoxybenzaldehyde

1.2 Other means of identification

Product number -
Other names 5-chloromethyl-4-hydroxy-3-methoxybenzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:28276-04-2 SDS

28276-04-2Relevant academic research and scientific papers

Tetrahydrocoptisine derivative and applications thereof

-

Paragraph 0271; 0275; 0276, (2016/10/08)

The present invention relates to a compound as shown in a formula (VII), a preparation method and applications thereof in medicines. In particular, the present invention relates to a derivative of the compound as shown in the formula (VII), a preparation method, and the applications of the derivative used as a therapeutic agent in prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, II-type diabetes, hyperglycemia, obesity or insulin resistance syndrome and metabolic syndrome. The compound disclosed by the present invention can also reduce total cholesterol, LDL-cholesterol and triglyceride, and increases expression of a liver LDL receptor and decreases expression of PCSK9.

An expeditious and convergent synthesis of ailanthoidol

Rao, Maddali L.N.,Awasthi, Dheeraj K.,Banerjee, Debasis

supporting information; experimental part, p. 1979 - 1981 (2010/06/21)

An expeditious and concise method has been described for the synthesis of ailanthoidol through convergent route starting from vanillin. The protocol involving intramolecular Wittig as a key reaction afforded ailanthoidol in overall high yield.

NOVEL MODULATORS OF PROTEIN KINASE SIGNALING

-

Page/Page column 66-67, (2009/12/28)

The present invention provides new tyrphostin derivatives acting as protein kinase (PK) and receptor kinase (RK) signaling modulators. The invention further provides methods of their preparation, pharmaceutical compositions including such compounds, and m

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 28276-04-2